Neogenomics, Inc.
NEO
$8.75
$0.091.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.84% | 1.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.84% | 1.26% | |||
| Cost of Revenue | -0.95% | -0.49% | |||
| Gross Profit | -2.97% | 3.60% | |||
| SG&A Expenses | 2.45% | -0.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.72% | -0.17% | |||
| Operating Income | -39.71% | 17.85% | |||
| Income Before Tax | -41.69% | 52.99% | |||
| Income Tax Expenses | 81.31% | -441.22% | |||
| Earnings from Continuing Operations | -73.12% | 63.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -73.12% | 63.58% | |||
| EBIT | -39.71% | 17.85% | |||
| EBITDA | -126.22% | 214.80% | |||
| EPS Basic | -72.40% | 63.65% | |||
| Normalized Basic EPS | -45.78% | 21.44% | |||
| EPS Diluted | -72.40% | 63.65% | |||
| Normalized Diluted EPS | -45.78% | 21.44% | |||
| Average Basic Shares Outstanding | 0.40% | 0.18% | |||
| Average Diluted Shares Outstanding | 0.40% | 0.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||